ArticleTranslational andrology and urology2025
Associations of different insulin resistance indices with the erectile dysfunction incidence: a cross-sectional analysis of the NHANES 2001-2004.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insulin resistance (IR) has been related to erectile dysfunction (ED). IR indices refer to calculation-based indices that estimate insulin sensitivity using routine clinical or biochemical parameters. However, there are fewer studies comparing the advantages of the relationship between different IR indices and ED. This study aimed to investigate the relationship between IR indices and the presence of ED. Methods: Data from the National Health and Nutrition Examination Survey (NHANES) 2001-2004 were analyzed. The associations of estimated glucose disposal rate (eGDR), triglyceride glucose (TyG) index, Homeostatic Model Assessment of IR (HOMA-IR), and TyG-body mass index (TyG-BMI) with ED were evaluated using weighted logistic regression and restricted cubic spline analysis. Results: There were 1,737 subjects examined. Only the eGDR was an independent predictor for ED in the model adjusted for all covariates in the weighted logistic regression analysis. Lower eGDR was associated with an increased risk of ED, even following covariate adjustment [continuous eGDR: odds ratio (OR) =0.91, 95% confidence interval (CI): 0.83-0.99, P=0.03; quartile 3 (Q3) Conclusions: eGDR was inversely associated with an increased risk of ED, suggesting that it might be as a potential and reliable predictor for ED incidence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.